drugset / Trial / NCT04399746
Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19
Non-randomizedParallel-groupOpen-labelTreatment
Summary
As the world faces COVID-19, the search for effective treatments against the disease and its complications has turned its gaze to drugs that are classically used in other infectious diseases. Some drugs are being examined for the recent evidence on its effects on viral replication and inflammation, one is Azithromycin, used to treat a wide variety of bacterial infections, Ivermectin, an anti-parasitic drug and the other is Cholecalciferol to increase serum concentration of 25-hydroxyvitamin D.
Timeline
- Start
- 2020-03-15
- Primary completion
- 2020-05-20
- Completion
- 2020-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | — |
| Subject | Cholecalciferol | Other / unclassified | 400 iu | — |
| Subject | Ivermectin | Small molecule | 6 mg | — |